Segment Information (Tables)
|
6 Months Ended |
Mar. 29, 2026 |
|---|
| Segment Reporting [Abstract] |
|
| Revenues and EBT for reportable segments |
The table below presents revenues and EBT for reportable segments (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | March 29,
2026 | | March 30,
2025 | | March 29,
2026 | | March 30,
2025 | | QCT: | | | | | | | | | Revenues | $ | 9,076 | | | $ | 9,469 | | | $ | 19,689 | | | $ | 19,553 | | | Cost of revenues | 4,700 | | | 4,834 | | | 10,145 | | | 9,898 | | | Operating expenses (R&D and SG&A) | 1,911 | | | 1,778 | | | 3,777 | | | 3,552 | | | EBT | $ | 2,465 | | | $ | 2,857 | | | $ | 5,767 | | | $ | 6,103 | | | QTL: | | | | | | | | | Revenues | $ | 1,382 | | | $ | 1,319 | | | $ | 2,974 | | | $ | 2,854 | | Costs and expenses (1) | 388 | | | 390 | | | 750 | | | 768 | | | EBT | $ | 994 | | | $ | 929 | | | $ | 2,224 | | | $ | 2,086 | | | QSI: | | | | | | | | | Revenues | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | | | | | | | | Operating expenses | 3 | | | 3 | | | 5 | | | 6 | | Investment and other (expense) income, net | (27) | | | 13 | | | 154 | | | 35 | | | EBT | $ | (30) | | | $ | 10 | | | $ | 149 | | | $ | 29 | |
(1) Substantially all of QTL’s costs and expenses are comprised of operating expenses.
|
| Reconciling items for reportable segments - revenues |
Consolidated revenues and EBT include the following reconciling items (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | March 29,
2026 | | March 30,
2025 | | March 29,
2026 | | March 30,
2025 | | Revenues | | | | | | | | | Reportable segments | $ | 10,458 | | | $ | 10,788 | | | $ | 22,663 | | | $ | 22,407 | | | Nonreportable segments | 141 | | | 48 | | | 188 | | | 99 | | Unallocated revenues | — | | | 143 | | | — | | | 143 | | | $ | 10,599 | | | $ | 10,979 | | | $ | 22,851 | | | $ | 22,649 | | | EBT | | | | | | | | Reportable segments | $ | 3,429 | | | $ | 3,796 | | | $ | 8,140 | | | $ | 8,218 | | | Nonreportable segments | (121) | | | (7) | | | (204) | | | (6) | | Unallocated revenues | — | | | 143 | | | — | | | 143 | | | Unallocated cost of revenues | (95) | | | (60) | | | (178) | | | (119) | | | Unallocated R&D expenses | (616) | | | (558) | | | (1,314) | | | (1,156) | | | Unallocated SG&A expenses | (274) | | | (184) | | | (573) | | | (372) | | Unallocated other expenses | (29) | | | — | | | (29) | | | — | | | Unallocated interest expense | (171) | | | (163) | | | (341) | | | (326) | | | Unallocated investment and other income, net | 109 | | | 138 | | | 278 | | | 358 | | | $ | 2,232 | | | $ | 3,105 | | | $ | 5,779 | | | $ | 6,740 | |
|
| Reconciling items for reportable segments - EBT |
Consolidated revenues and EBT include the following reconciling items (in millions): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | March 29,
2026 | | March 30,
2025 | | March 29,
2026 | | March 30,
2025 | | Revenues | | | | | | | | | Reportable segments | $ | 10,458 | | | $ | 10,788 | | | $ | 22,663 | | | $ | 22,407 | | | Nonreportable segments | 141 | | | 48 | | | 188 | | | 99 | | Unallocated revenues | — | | | 143 | | | — | | | 143 | | | $ | 10,599 | | | $ | 10,979 | | | $ | 22,851 | | | $ | 22,649 | | | EBT | | | | | | | | Reportable segments | $ | 3,429 | | | $ | 3,796 | | | $ | 8,140 | | | $ | 8,218 | | | Nonreportable segments | (121) | | | (7) | | | (204) | | | (6) | | Unallocated revenues | — | | | 143 | | | — | | | 143 | | | Unallocated cost of revenues | (95) | | | (60) | | | (178) | | | (119) | | | Unallocated R&D expenses | (616) | | | (558) | | | (1,314) | | | (1,156) | | | Unallocated SG&A expenses | (274) | | | (184) | | | (573) | | | (372) | | Unallocated other expenses | (29) | | | — | | | (29) | | | — | | | Unallocated interest expense | (171) | | | (163) | | | (341) | | | (326) | | | Unallocated investment and other income, net | 109 | | | 138 | | | 278 | | | 358 | | | $ | 2,232 | | | $ | 3,105 | | | $ | 5,779 | | | $ | 6,740 | |
|